Introduction: International travel is a significant contributor to the acquisition of sexually transmissible infections (STIs). Despite the high volume of outbound travel from Australia, peaking at 10.8 million travellers in 2023, limited data exist on the burden of overseas-acquired STIs. This study aims to investigate the burden and trends of overseas- and locally-acquired STIs in Australia.
Methods: We analysed STI cases notified to Australia's National Notifiable Diseases Surveillance System (NNDSS) from January 2017 to December 2023. A comparative analysis was conducted by place of acquisition (i.e., overseas versus local), with the geographical origins of overseas-acquired cases mapped using ArcMap and temporal trends assessed across pre-COVID-19, pandemic, and post-pandemic periods.
Results: A total of 967,193 records were obtained from NNDSS, of which 188,788 STI cases (11,782 overseas- and 177,006 locally-acquired) were included in the analysis. Males were the most affected group (63% of overseas- and 60% of locally-acquired), and young adults aged 20-24 year represented a quarter of cases (24.6% of overseas- and 25.9% of locally-acquired). The incidence of overseas-acquired STIs cases rose nearly 3-fold, from 12.8 per 100,000 travellers in 2017 to 35.0 per 100,00 travellers in 2019, then declined during the COVID-19 pandemic due to Australia's travel restrictions to 16.4 per 100,000 travellers in 2020. A surge was observed in 2021, with 46.5 per 100,000 travellers. The most common regions of acquisition were Southeast Asia (n=2,390, 44.6%), North and South America (n=663, 12.4%), and Northwest Europe (n=580, 10.8%).
Conclusions: This study highlights the patterns of overseas- and locally-acquired STIs in Austrlia, with chlamydia remaining the most prevalent (but declining since 2021), while gonorrhoea has been increasing, among overseas-acquired cases. Variations in region of acqusition and demogrpahic factors highlight the critical need for tailored safer-sex advice during pre-travel consultations, particularly for males and young adults travelling to high-prevalence destinations.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/jtm/taaf022 | DOI Listing |
J Travel Med
March 2025
UQ Centre for Clinical Research, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Herston, Australia.
Introduction: International travel is a significant contributor to the acquisition of sexually transmissible infections (STIs). Despite the high volume of outbound travel from Australia, peaking at 10.8 million travellers in 2023, limited data exist on the burden of overseas-acquired STIs.
View Article and Find Full Text PDFJ Travel Med
December 2024
UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Building 71/918 RBWH Herston, Brisbane, QLD 4029, Australia.
Philos Trans R Soc Lond B Biol Sci
January 2024
Environmental Health, Flinders University, GPO Box 2100, Adelaide, South Australia 5001, Australia.
In Australia, strongyloidiasis primarily affects returned travellers, Vietnam veterans and refugees or asylum seekers, and First Nations people. Non-overseas acquired cases are seen almost exclusively in Australian First Nations remote communities. Australian First Nations communities have one of the highest rates of strongyloidiasis in the world.
View Article and Find Full Text PDFMed Trop Sante Int
March 2023
Unité Parasitologie et entomologie, Département Microbiologie et maladies infectieuses, Institut de recherche biomédicale des armées, 19-21 bd Jean Moulin, 13005 Marseille, France.
Mayotte is a French overseas department and one of the 4 islands of the Comoros archipelago in the Indian Ocean, located between Madagascar and the eastern coast of Africa. Malaria, mainly by , is endemic to the archipelago and remained a major public health problem until recent years. To control and then eliminate the disease, major strategies have been established in Mayotte since 2001.
View Article and Find Full Text PDFLancet Reg Health West Pac
December 2021
Department of Health, 50 Lonsdale Street, Melbourne, Victoria 3000, Australia
Background: Victoria experienced the greatest burden of COVID-19 in Australia in 2020. This report describes key epidemiological characteristics and corresponding control measures between 17 January 2020 and 26 March 2021.
Methods: COVID-19 notifications made to the State Government Department of Health were used in this analysis.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!